Home » Glenmark Generics Gets U.S. FDA Nod for Cirrhosis Drug
Glenmark Generics Gets U.S. FDA Nod for Cirrhosis Drug
Glenmark Generics has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for Ursodiol tablets used in treatment of patients with primary biliary cirrhosis (PBC).
Moneycontrol
Moneycontrol
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May